SLVM vs CHRN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SLVM · Sylvamo$39.38 ▲ 19.08%
CHRN · ChronoScale$10.75 ▲ 5.81%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SLVM -3.8%
- CHRN +115.0%
Head to head
| Metric | SLVM | CHRN |
|---|---|---|
| Price | $39.38 | $10.75 |
| Change today | ▲ 19.08% | ▲ 5.81% |
| Market cap | $1.57B | $1.57B |
| Return, 3 months | -0.9% | -44.6% |
| Return, year to date | -14.4% | +24.4% |
| Return, 1 year | -4.3% | +130.2% |
| P/E (TTM) | 21.1 | – |
| P/B | 1.6 | 10.4 |
| P/E percentile vs own 5y | 88th | 8th |
| Dividend yield | 5.71% | – |
| Revenue growth (YoY, latest qtr) | +1.5% | +148.1% |
| Net profit growth (YoY) | -173.3% | -277.9% |
| Gross margin | 20.6% | -14.6% |
| Operating margin | 5.8% | -56.3% |
| Net margin | 2.3% | -84.6% |
| Return on equity | 7.9% | -54.1% |
| Analyst target vs. price | +4.1% | +165.1% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 71 | 32 |
| 30-day volatility | 66.1% | 110.7% |
| Max drawdown, 1 year | -41.0% | -65.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SLVM is the largest of the group by market value.
- CHRN has returned the most over the past year.
- CHRN is growing revenue fastest.
- SLVM keeps the most profit per dollar of sales.
- SLVM has been the calmest stock over the last 30 days.